2020, Volume 27, Issue 4

Background: Survival analysis refers to analyzing of statistical data for which the outcome variable of interest is time until an event occurs. This research aimed at comparing different models of parametric Proportional Hazards (PH) models (Weibull, exponential, Gompertz) in patients […]

Read More… from Parametric Survival Models of Hemodialysis Patients in Relation with Patient-Related Factors

First line anti-tubercular drugs are known to cause various adverse drug reactions including cutaneous reactions. We report a rare case of anti-tubercular treatment (ATT) induced lichenoid skin reaction in a 58 years old female with no prior history of rashes. […]

Read More… from Lichenoid Skin Reaction in a Patient on Anti-Tubercular Drugs: a Rare Case Report

Bevacizumab is a monoclonal antibody which has shown promising results in the treatment of varied malignant pathology, including metastasized colorectal cancer. It acts by inhibiting VEGF (vascular endothelial growth factor), and one of its most cited complications is intestinal perforation, […]

Read More… from Double Perforation after Colorectal Cancer Surgery During Bevacizumab Treatment

Bone metastasis is a severe complication of malignant tumors. Management of multiple bone metastases remains difficult and prognosis is generally unfavorable, radiotherapy being often the therapeutic option. The main goals of the palliative irradiation of bone metastases are the reduction […]

Read More… from Palliative Re-Irradiation of Bone Metastases – Case Report

We present the case of a 71 year old female that was endoscopically diagnosed with type III neuroendocrine gastric tumor (NET). NETs are rare, slowly growing neoplasm originating in the neuroendocrine cells, that can occur anywhere in the body. Gastrointestinal […]

Read More… from Type III Gastric Neuroendocrine Tumor – a Case Report